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Abstract
Background: Chronic pain occurs when normally protective acute pain becomes pathologically persistent. We
examined here whether an isoform of protein kinase C (PKC), PKMζ, that underlies long-term memory storage in
various brain regions, also sustains nociceptive plasticity in spinal cord dorsal horn (SCDH) mediating persistent
pain.
Results: Cutaneous injury or spinal stimulation produced persistent increases of PKMζ, but not other atypical PKCs
in SCDH. Inhibiting spinal PKMζ, but not full-length PKCs, reversed plasticity-dependent persistent painful responses
to hind paw formalin and secondary mechanical hypersensitivity and SCDH neuron sensitization after hind paw
capsaicin, without affecting peripheral sensitization-dependent primary heat hypersensitivity after hind paw
capsaicin. Inhibiting spinal PKMζ, but not full-length PKCs, also reversed mechanical hypersensitivity in the rat hind
paw induced by spinal stimulation with intrathecal dihydroxyphenylglycine. Spinal PKMζ inhibition also alleviated
allodynia 3 weeks after ischemic injury in rats with chronic post-ischemia pain (CPIP), at a point when allodynia
depends on spinal changes. In contrast, spinal PKMζ inhibition did not affect allodynia in rats with chronic
contriction injury (CCI) of the sciatic nerve, or CPIP rats early after ischemic injury, when allodynia depends on
ongoing peripheral inputs.
Conclusions: These results suggest spinal PKMζ is essential for the maintenance of persistent pain by sustaining
spinal nociceptive plasticity.
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Background
Chronic pain follows the transition from normally pro-
tective acute pain to pathological persistent pain, and
depends on neuronal plasticity in SCDH [1,2]. Protein
kinases, such as PKC, contribute to nociceptive plasticity
in SCDH [3]. Specific isoforms of PKC, including PKCb-
II, PKCε, PKCg and PKCζ are upregulated in SCDH
after persistent pain [4-8], and persistent pain is relieved
by inhibition/knock-out of these isoforms [9-11].
Although studies implicate full-length PKCs in the
induction of spinal nociceptive plasticity, the mechan-
isms that sustain nociceptive plasticity underlying persis-
tent pain are unknown.
An independent C-terminal domain of PKCζ, known
as PKMζ, exists as an autonomously-active isoform.
PKMζ is generated by an internal promoter within the
PKCζ gene that encodes only the catalytic domain [12].
New synthesis of PKMζ is necessary and sufficient for
maintenance of hippocampal long-term potentiation
(LTP) [13,14], and long-term memory storage in various
brain regions [15-17]. Given there are similarities in the
neuronal mechanisms underlying both hippocampal
LTP and spinal nociceptive plasticity [18], including a
key role for PKC in hippocampal LTP [19,20], we expect
that PKMζ may also contribute to the maintenance of
spinal plasticity underlying persistent nociception.
A recent study shows that neuropathic pain in mice is
reduced by inhibiting PKMζ in cingulate cortex, but not
SCDH [21]. However, since the specific contribution of
PKMζ to the maintenance of plasticity in neuropathic
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pain is confounded by ongoing peripheral inputs, it is
important to assess the effects of PKMζ inhibition in an
animal model of persistent pain, where allodynia
depends on central changes independent of ongoing
peripheral inputs.
PKMζ has also been shown to contribute to spinal
nociceptive priming [22], although it is unknown
whether PKMζ maintains spinal plasticity allowing acute
stimuli to generate persistent pain, clinically a critical
step in progression from acute to chronic pain [23,24].
Furthermore, while inhibitors of full-length PKCs have
been shown to be involved in the induction of nocicep-
tive sensitization in SCDH neurons [25,26], it is
unknown whether PKMζ contributes to the mainte-
nance of this sensitization.
Here we examine whether PKMζ is selectively
involved in sustaining spinal plasticity essential for per-
sistent pain, and underlies persistent pain, pain hyper-
sensitivity and/or SCDH neuronal sensitization following
cutaneous injury or direct spinal stimulation. We also
examine whether PKMζ inhibition selectively reverses
chronic allodynia that depends on central changes, as
opposed to ongoing peripheral inputs.
Results
Spinal PKMζ is upregulated after cutaneous injury
We first examined whether cutaneous injuries that
induce persistent pain produced changes in expression
of the 3 atypical PKC isozymes, PKMζ, PKCζ and PKCι/
l, in rat SCDH using an antibody raised against the C-
terminal PKCζ that recognizes all three species [12].
Rats were given an intraplantar (i.pl.) hind paw injection
of 2.0% formalin, 0.1% capsaicin or vehicle, and PKMζ,
PKCζ and PKCι/l were assayed by Western blot in
SCDH homogenates at various time points after injury.
Compared to levels in vehicle-treated rats, PKMζ, as
well as PKCζ and PKCι/l expression were substantially
increased in SCDH 45 min after formalin (Figure 1a,b),
but only PKMζ was increased 2-24 h after capsaicin
(Figure 2a,b) injection. Thus, injuries causing persistent
nociception produce sustained increases in spinal PKMζ,
but transient increases (< 2 h) in PKCζ and PKCι/l.
Spinal PKMζ contributes to persistent pain after
cutaneous injury
We next compared the effects of intrathecal (i.t.) pre- or
post-treatment of a cell membrane-permeable PKMζ
inhibitor myristoylated-ζ-pseudosubstrate inhibitory
peptide (ZIP), or its scrambled control peptide (scr-ZIP),
on persistent pain induced by i.pl. formalin. We have
previously shown that persistent “late phase” formalin
pain depends largely on spinal plasticity that occurs in
response to pain during an acute early phase [27]. Here
we compared the effects of ZIP with the PKC inhibitor
Figure 1 SCDH atypical PKC expression, and effects of PKMζ/PKC
inhibition on formalin nociception. (a) Western blots and (b)
histograms (% change) of atypical PKC showing i.pl. formalin
increased PKMζ, PKCζ and PKCι/l (n = 5/6 for vehicle/formalin) in
SCDH (*P < 0.05). (c) Effect of ZIP on rotarod latencies, which
significantly increased over training (*p < 0.05 from day 1). Latencies
on day 6 (after ZIP) did not differ from day 5 (n.s.: non-significant
difference). (d,e) Dose-dependent effects of pretreatment with ZIP (n
= 5-7/dose) vs. scr-ZIP (n = 7) (d) or NPC-15437 (n = 5-7/dose) vs.
vehicle (n = 8) (e) on formalin pain. ZIP dose-dependently reduced
late phase (9-45 min) scores (†P < 0.05, *P < 0.01 red dash-boxed or
individual symbols from scr-ZIP), but not early phase scores (0-6
min). NPC-15437 also significantly reduced late phase scores (†P <
0.05, *P < 0.01 for red dash-boxed or individual symbols), but not
early phase scores. (f,g) Effect of ZIP (n = 6) or scr-ZIP (n = 4)
pretreatment on von Frey paw-withdrawal thresholds (PWT, f) or
plantar test paw-withdrawal latencies (PWL, g) in naïve rats. Neither
ZIP nor scr-ZIP significantly affected either PWTs or PWLs. (h,i)
Painful responses induced by formalin before and after ZIP (n = 5)
or scr-ZIP (n = 5) (h), and NPC-15437 (n = 5) or vehicle (n = 7) (i),
administered 25 min post-formalin. ZIP (*P <.05), but not NPC-15437,
significantly attenuated persistent formalin pain. For these and
subsequent graphs ZIP, scr-ZIP, NPC-15437 and vehicle were given i.
t., and data is expressed as means ± s.e.m. unless otherwise stated.
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NPC-15437, which inhibits all PKC isoforms except
PKMζ, since it binds within the regulatory domain of
PKC [28] (which is absent in PKMζ). Compared to scr-
ZIP, pretreatment with 0.5-20 nmoles of i.t. ZIP signifi-
cantly reduced persistent pain, but not acute formalin
pain (Figure 1d). A dose of 10 nmoles was used subse-
quently since it had no significant effects on motor
coordination in the rotarod test (Figure 1c), or on noci-
ceptive thresholds to heat or mechanical stimulation in
naïve rats (Figure 1f,g). Post-treatment with 10 nmoles i.
t. ZIP, but not scr-ZIP, also significantly reversed persis-
tent formalin pain when given 25 min post-formalin
(Figure 1h). Further, despite analgesia in the formalin
test induced by pretreatment with the full-length PKC
inhibitor NPC-15437 (Figure 1e), post-treatment with
NPC-15437 had no effect on persistent formalin pain
(Figure 1i). Thus, unlike PKMζ, full-length PKCs are
likely involved in inducing, but not sustaining, the noci-
ceptive plasticity underlying persistent formalin pain.
Moreover, together with our biochemical results, these
data indicate that although both PKC (ζ and ι/l) and
PKMζ are increased by formalin, the sustained plasticity
that underlies persistent late pain depends on PKMζ.
Spinal PKMζ contributes to pain hypersensitivity after
cutaneous injury
We next determined the effects of PKMζ inhibition on
pain hypersensitivity induced by hind paw capsaicin
injection. Capsaicin was used to distinguish the separate
contributions of acute peripheral nociceptor sensitiza-
tion and persistent central neuroplasticity to pain hyper-
sensitivity. In both humans [29] and rats [30], skin
injury with capsaicin produces spontaneous pain lasting
~15 min, and subsequently an early (2 h) localized pri-
mary heat hyperalgesia that depends on peripheral noci-
ceptor sensitization, and a persistent (~24 h), wide-
spreading secondary mechanical allodynia (an important
feature of chronic pain) that for humans has been
shown to depend on central neuroplasticity [29]. We
show secondary mechanical allodynia 24 h after intra-
dermal (i.d.) capsaicin injection in rats likely also
depends on central neuroplasticity, as it is maintained
after local anesthesia of the capsaicin injection site (Fig-
ure 2c,d). We hypothesized that if PKMζ is involved in
sustaining spinal plasticity underlying persistent pain
then i.t. ZIP should reverse the secondary mechanical
allodynia even when given well after the injury. Impor-
tantly, i.t. ZIP, but not scr-ZIP, reversed secondary
mechanical allodynia when given 24 h post-capsaicin
(Figure 2e). In contrast, the full-length PKC inhibitor,
NPC-15437, was unable to reverse secondary mechanical
allodynia (Figure 2f) when given at the same time point.
Thus, spinal PKMζ, but not full-length PKCs, is involved
in sustaining spinal plasticity underlying persistent
Figure 2 SCDH atypical PKC expression, and effects of PKMζ/PKC
inhibition on capsaicin-induced allodynia. (a) Western blots and
(b) histograms (% change) of atypical PKC showing i.pl. capsaicin
increased PKMζ, but not PKCζ or PKCι/l, in SCDH from 2-24 h (*P <
0.05, n = 7/12 vehicle/capsaicin). c) Primary/secondary allodynia test
sites in capsaicin-injected rats. d) Paw-withdrawal thresholds (PWTs)
24 h post-capsaicin after anesthesia (n = 5) or no-anesthesia (n = 5)
of the primary site. Primary, but not secondary, allodynia was
attenuated by anesthesia (*P < 0.05, from no-anesthesia). (e,f) Pre-
and post-capsaicin PWTs (g) with ZIP, scr-ZIP, NPC-15437 or vehicle
(n = 15,4,6,6, respectively) given 24 h post-capsaicin. ZIP (*P < 0.05),
but neither scr-ZIP nor NPC-15437, significantly reversed capsaicin-
induced allodynia 40-120 min post-drug. (g,h) Effect of ZIP given 20
min before testing on paw-withdrawal latencies, PWLs (s) and PWTs
(g) 24 h after capsaicin or vehicle (n = 6,4, respectively). g) Heat
hyperalgesia present at 2 h post-capsaicin (*P < 0.05, from vehicle),
abated by 24 h, and PWLs were unaffected by ZIP. h) Mechanical
allodynia 24 h post-capsaicin (*P < 0.05 from vehicle) was reversed
by ZIP. (i,j) Effect of ZIP or scr-ZIP (n = 11, 8, respectively) 100 min
post-capsaicin on PWLs and PWTs 20 min, 2 and 24 h post-
capsaicin. i) Heat hyperalgesia (20 min-2 h, †P < 0.05 from baseline),
abated by 24 h, and was unaffected by ZIP at 2-24 h post-capsaicin.
j) Mechanical allodynia was significantly attenuated at 2 h, and
reversed at 24 h, post-capsaicin by ZIP (*P < 0.05 from scr-ZIP).
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secondary pain hypersensitivity. Furthermore, the
mechanical allodynia (at 2 and 24 h post-capsaicin), but
not peripheral nociceptor sensitization-mediated, heat
hyperalgesia (at 2 h post-capsaicin) was attenuated by i.
t. ZIP, but not scr-ZIP, given early (100 min) or late (24
h) post-capsaicin (Figures 2g-j). Thus, ZIP reversed the
persistent mechanical allodynia dependent on central
sensitization, but not acute heat hyperalgesia dependent
on peripheral nociceptor sensitization. Although ZIP
treatment attenuated mechanical allodynia at 2 h (Figure
2j), it likely did not completely reverse it, because there
was still an important contribution of primary sensitiza-
tion at this point (note that testing was not performed
separately at primary and secondary sites in this trial to
due a larger capsaicin injection volume needed to
induce heat hyperalgesia).
Spinal PKMζ contributes to capsaicin-induced
sensitization of WDR neurons
We also show that spinally-administered ZIP, but not
scr-ZIP, when given 90 min after hind paw capsaicin,
reversed the sensitization of spinal wide-dynamic-range
(WDR) neurons to mechanical stimulation (Figure 3a,c-
e). Importantly, ZIP had no effect on a WDR neuron
that was not sensitized by capsaicin (Figure 3b), or
when given after hind paw vehicle injection which does
not sensitize WDR neurons (Figure 3f-h), indicating that
ZIP reverses spinal sensitization, but does not simply
suppress all stimulation-evoked activity. Although over-
all background activity of WDR neurons was increased
by hind paw capsaicin injection, we did not see an
increase in the evoked responses to noxious heat (Figure
3i). Furthermore, ZIP failed to reduce the significant
capsaicin-induced increase in background activity of
WDR neurons (Figure 3j).
Spinal PKMζ is upregulated and contributes to pain
hypersensitivity after spinal stimulation
We next examined whether i.t. ZIP affected persistent
pain hypersensitivity induced by direct activation of
spinal neurons with the metabotropic glutamate receptor
agonist dihydroxyphenylglycine (DHPG). We have pre-
viously shown that i.t. DHPG produces acute pain (~60
min), followed by persistent mechanical allodynia [31].
Here we show i.t. DHPG sensitized a spinal WDR neuron
to mechanical stimuli (Figure 4a), and increased PKMζ,
but not PKCζ or PKCι/l, in SCDH at 2-24 h (Figure 4b,
c). Furthermore, mechanical allodynia induced 24-72 h
after 10 nmoles of i.t. DHPG was reversed by i.t. ZIP, but
not scr-ZIP, given 20 min before the 24 h test (Figure
4d). Once again these effects could not be replicated by
inhibition of spinal full-length PKCs (Figure 4e), stressing
the specific role of PKMζ in sustaining spinal plasticity;
this time after direct spinal stimulation.
Inhibition of spinal PKMζ reverses mechanical allodynia in
CPIP, but not CCI rats
Finally, we assessed the effects of PKMζ inhibition in
animal models of chronic pain, including chronic post-
ischemia pain (CPIP) and chronic constriction injury
(CCI) of the sciatic nerve. We tested the hypothesis that
chronic models for which ongoing inputs from periph-
eral pathology are critical for allodynia would be less
sensitive to the anti-allodynic effects of spinal PKMζ
inhibition, than those in which the allodynia depends
more on central changes. Thus, rats with CCI have allo-
dynia dependent on persistent ongoing inputs from the
constricted sciatic nerve [32,33], whereas CPIP rats initi-
ally have allodynia dependent on peripheral pathology
(microvascular dysfunction and lactate accumulation in
muscle), and later, once microvascular dysfunction
resolves between 2-3 weeks, have continuing allodynia
that is dependent on spinal changes [34]. We show that
allodynia in late CPIP rats (3 weeks post-injury) is sig-
nificantly alleviated by i.t. ZIP, but not scr-ZIP (Figure
4f). In contrast, allodynia in CCI rats, or in early CPIP
rats (3-4 days post-injury), is not significantly affected
by i.t. ZIP (Figure 4f).
Discussion
Full-length PKCs in SCDH have previously been shown
to contribute to the induction of pain hypersensitivity,
or allodynia and hyperalgesia and neuronal sensitization
that are driven largely by continued inputs from the per-
ipheral site of injury [4,5,8]. The present results, how-
ever, indicate the autonomous PKC isoform, PKMζ,
plays a specific essential role in sustaining spinal plasti-
city underlying persistent pain. PKMζ was persistently
increased in SCDH by cutaneous injuries (i.pl. formalin
and capsaicin), or by spinal stimulation with a glutamate
agonist, each of which produces persistent pain or long-
lasting pain hypersensitivity that is selectively reversed
by inhibition of PKMζ, but not full-length PKCs. Addi-
tional shorter-term increases in full-length PKCζ and
PKCι/l 45 min after i.pl. formalin injection are consis-
tent with the behavioral data suggesting a role of full-
length PKCs in the induction of persistent pain. How-
ever, at later time points (2 and 24 h) after i.pl. capsaicin
or i.t. DHPG, only PKMζ is elevated, indicating that
SCDH PKMζ specifically is persistently elevated in asso-
ciation with the maintenance of persistent pain.
The specificity of PKMζ effects in sustaining spinal
plasticity underlying persistent pain is highlighted by the
ability of i.t. treatment with a selective PKMζ inhibitor
to reverse established persistent pain or pain hypersensi-
tivity, while treatment with a full-length PKC inhibitor
fails to do so, despite its ability to prevent the induction
of persistent pain. This transition from the transient
role of full-length PKCs to the persistent function of
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Figure 3 Effects of PKMζ inhibition on capsaicin-induced sensitization of spinal WDR neurons. (a,b) Spike rate (spikes/sec) of evoked
responses of 2 WDR neurons to von Frey filaments pre- and post-capsaicin. ZIP (90 min post-capsaicin) reduced the capsaicin-induced
sensitization of mechanically-evoked responses of the neuron in (a). The neuron in (b) was not sensitized by capsaicin, and ZIP did not reduce
evoked responses to the mechanical stimuli. (c-e) Mechanically-evoked WDR neuron responses to 1 (c), 5 (d) or 20 (e) g stimuli pre- and post-
capsaicin (% of baseline action potentials evoked/20 s). ZIP, but not scr-ZIP (n = 6, 5, respectively), significantly reversed capsaicin-enhanced
evoked responses to 5-20 g stimuli at 30-60 min post-drug (*P < 0.05). (f-h) Mechanically-evoked WDR neuron responses to 1 (f), 5 (g) or 20 (h)
g stimuli pre- (baseline, BL) and post-vehicle (before (Veh) and after ZIP (30-60 min) applied 90 min post-vehicle) (n = 5). Neither i.pl. vehicle, nor
i.t. ZIP, significantly affected evoked responses of WDR neurons. i) Background activity and evoked responses to heat pre- and post-capsaicin.
Although capsaicin significantly increased the background activity of WDR neurons (** P < 0.01 from Pre-capsaicin), it failed to increase their
heat-evoked responses (P >0.05, n = 8). j) Background activity of WDR neurons pre- (baseline, BL) and post-capsaicin (before (Cap) and after ZIP
(30-60 min) applied 90 min post-capsaicin, n = 6). Capsaicin significantly increased background activity (*P < 0.05), and ZIP failed to significantly
reduce the capsaicin-induced increase in the background activity of WDR neurons (P > 0.05).
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autonomously active PKMζ in pain is reminiscent of
similar transitions in LTP and memory consolidation
[13-17]. Furthermore, the finding that spinal PKMζ inhi-
bition not only reversed hind paw capsaicin-induced
allodynia, but also hind paw capsaicin-induced sensitiza-
tion of SCDH WDR neurons (evoked by the same
mechanical stimuli) provides further support for the role
of PKMζ in the maintenance of spinal nociceptive plasti-
city. Earlier studies demonstrating that pretreatment
[25], but not post-treatment [26] with NPC-15437
reduced capsaicin-induced sensitization of spinal neu-
rons to mechanical stimulation, is also consistent with
our behavioral data showing that post-treatment with
NPC-15437 does not reverse persistent pain or allodynia
after cutaneous injury or spinal stimulation. Importantly,
this earlier study used the same PKC inhibitor we
employed, which does not inhibit PKMζ.
Our results are consistent with and extend upon three
recent papers that have examined the role of PKMζ in
nociception [21,22,35]. The first paper showed that
Figure 4 SCDH atypical PKC expression, and effects of PKMζ/PKC inhibition on spinal DHPG-induced allodynia. (a) Spike rate (spikes/sec) of
evoked responses of a WDR neuron to 20 and 50 g von Frey filaments before and 5 or 25 min after DHPG. Note the increased evoked
responses to both mechanical stimuli, and the prolonged after-discharges to the 50 g stimulus, both 5 and 25 min post-DHPG. Scale bar (20
sec). (b) Western blots and (c) histograms of % change in atypical PKC levels compared to vehicle illustrating that i.t. DHPG significantly
increased PKMζ (n = 12), but not PKCζ (n = 12) or PKCι/l (n = 8) in SCDH (vehicle, n = 11), 2 and 24 h post-DHPG combined (*P < 0.05). (d,e)
Pre- and post-DHPG paw withdrawal thresholds (PWTs, g) for rats given i.t. ZIP or scr-ZIP (d), i.t. NPC-15437 or vehicle (e), 30 min prior to testing
at 24 h post-DHPG, with additional testing 48 h post-drug. ZIP (*P < 0.05), but not scr-ZIP or NPC-15437, reversed DHPG-induced mechanical
allodynia at both time-points (n = 5 for each drug). f) Pre-drug (base) and post-drug PWTs of CCI rats (n = 8), early CPIP rats (n = 9) and late
CPIP rats treated with i.t. ZIP (n = 7), or late CPIP rats treated with i.t. scr-ZIP (n = 8). ZIP, but not scr-ZIP, reversed allodynia in late CPIP rats,
while ZIP had no effects in CCI or early CPIP rats (* P < 0.01; ** P < 0.001 from scr-ZIP; † P < 0.05; †† P < 0.01 from pre-drug baseline).
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PKMζ was increased within the anterior cingulate cortex
(ACC) of neuropathic mice, and that PKMζ inhibition in
this brain area, but not SCDH, produced anti-allodynic
effects in neuropathic mice [21]. A role of PKMζ in
nerve-injury induced neuronal plasticity in ACC was
further supported since ZIP reduced a-amino-3-
hydroxy-5-methyl-4-isoxazole-propionate (AMPA)
receptor-mediated excitatory post-synaptic potentials
(EPSPs) in ACC neurons of nerve-injured, but not sham
mice. Additionaly, PKMζ inhibition reduced spinal neu-
ron AMPA receptor-mediated EPSPs in nerve-injured,
as well as sham mice [21]. Importantly, these electro-
physiological experiments were performed in brain and
spinal cord slices, where there are no longer ongoing
inputs from the injured nerves. However, the lack of
effect of spinal PKMζ inhibition on allodynia does not
rule out a role for PKMζ in spinal plasticity, if the inhi-
bitor is unable to overcome the effects of ongoing inputs
from injured nerves. Thus, our results, showing a lack of
anti-allodynic effect of spinal ZIP in CCI rats, support
the findings of Li et al. [21] in neuropathic mice. How-
ever, we found that i.t. ZIP relieved allodynia in late
CPIP rats, in which allodynia depends on central
changes (as peripheral pathology has resolved), but not
for early CPIP rats, in which allodynia depends on
ongoing peripheral inputs [34]. This suggests that while
PKMζ may contribute to spinal plasticity in these mod-
els, the ability of spinal PKMζ inhibition to relieve allo-
dynia is overshadowed in CCI rats or early CPIP rats
when there is significant ongoing peripheral input.
The second paper showed that inhibition of PKMζ in
spinal cord prevented the enhancement of allodynia (in
response to cutaneous injury) or persistent pain (in
response to i.t. DHPG) that occurred following an ear-
lier resolved cutaneous injury (either i.pl. IL-6 injection
or plantar incision) [22]. In this case, PKMζ inhibition
was shown to prevent the development of enhanced
responses to nociceptive stimulation in situations where
an earlier injury results in nociceptive priming. Our
results support this earlier study’s conclusions, extend-
ing them to include ZIP’s ability to reverse an estab-
lished persistent pain or pain hypersensitivity.
Importantly, Asiedu et al. [22] did not reverse allodynia,
but rather prevented allodynia induced by a second
injury. Together the two studies strongly implicate the
role of PKMζ in maintaining spinal nociceptive plasticity
for both nociceptive priming and persistent pain.
Our data is also consistent with a recent third report
published in this journal showing that PKMζ activity
(specifically localized in spinal projection neurons) is
increased after formalin injury, and that a PKMζ inhibi-
tor reduced nociceptive behaviors, WDR neuronal activ-
ity and Fos protein levels in SCDH in response to hind
paw formalin injection [35]. However, these investigators
only examined the effects of pretreatment with ZIP on
formalin-induced nociceptive and dorsal horn neuronal
responses. While data here and in this previous study
implicate a role of PKMζ in the induction of nociceptive
plasticity; the current study, showing a post-treatment
reversal of formalin-induced persistent nociception, as
well as allodynia and WDR sensitization induced by
hind paw capsaicin, and allodynia induced after i.t.
DHPG, or in late CPIP rats, also implicates PKMζ in the
maintenance of spinal nociceptive plasticity in persistent
pain.
Marchand et al. [35] also showed that spinal PKMζ
inhibition was unable to reduce mechanical hypersensi-
tivity in neuropathic animals, although they did show
that ZIP post-treatment attenuated mechanical hyper-
sensitivity in rats with complete Freund’s adjuvant
(CFA)-induced hind paw inflammation. However, the
effect on mechanical hypersensitivity was only partial
and short-lived (30 min), with slightly better effects on
thermal hypersensitivity. These investigators attributed
the differential effects of ZIP on neuropathic and
inflammatory pain to disparate molecular mechanisms
of nociceptive plasticity underlying these two injuries.
However, based on the differential effects of ZIP in CCI
and early CPIP rats vs. late CPIP rats observed in our
study, the disparate results could also be explained by
differences in the contribution of ongoing inputs from
injured peripheral tissue, which are particularly
enhanced in neuropathic animals [32,33], and we expect
are reduced in late CPIP rats when the injured tissue
has healed [34]. While it is true that there may be
ongoing peripheral inputs in CFA rats, it could also be
argued that the high levels of spontaneous C- and Aδ-
and A-b fiber activity in damaged peripheral nerves in
CCI rats (generated both at the site of injury and at the
dorsal root ganglion [32,33]) may represent greater per-
ipheral drive. Furthermore, peripheral drive from
inflamed CFA hind paws may explain the partial and
short-lived effects of i.t. ZIP on mechanical and thermal
hypersensitivity in these animals.
Conclusions
The present results implicate spinal PKMζ as a key
mediator sustaining plasticity in SCDH underlying per-
sistent pain. Thus, persistent pain, pain hypersensitivity
and the sensitization of SCDH neurons after cutaneous
injury, or chronic allodynia after ischemia injury, all
depend on PKMζ for their maintenance. The specific
role of PKMζ in sustaining spinal nociceptive plasticity
contrasts with the role of full-length PKCs, which
appears to play a role only in its induction. The results
suggest that spinal PKMζ may be an important new tar-
get for the development of pharmacological therapies
for chronic pain.
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Methods
Subjects
Subjects were male Long-Evans hooded rats obtained
from Charles River (Senneville, QC). The rats were
housed 3 to a cage and were maintained on a 12 h
light/dark cycle with food and water available ad libi-
tum. All procedures were carried out during the light
cycle, and with approval of the McGill University Ani-
mal Care Committee.
Injuries or stimuli inducing allodynia and hyperalgesia
Cutaneous injuries were induced by intraplantar (i.pl.)
injections of either formalin (Sigma, 2.0%, 50 μl, in 0.9%
saline) or capsaicin (Sigma, 0.1%, 20 μl for trials with
heat hyperalgesia or 0.5%, 10 μl intradermally (i.d.) for
trials with secondary mechanical allodynia, in 7.5%
Tween 80/saline). Direct spinal stimulation was pro-
duced by intrathecal (i.t.) injection of 10 nmoles of dihy-
droxyphenylglycine (DHPG, Tocris, in 20 μl) [31].
Within 45 min post-formalin, or for periods between 2-
72 h post-capsaicin or post-DHPG, rats were subjected
to behavioral nociceptive testing or SCDH electrophy-
siological recording, or had their spinal cords removed
by pressure ejection following sodium pentobarbital
anesthesia and decapitation.
Neuropathic injury was induced by chronic constric-
tion injury (CCI) of the sciatic nerve, as described by
Bennett and Xie [36]. Briefly, while rats were under
sodium pentobarbital anesthesia, the sciatic nerve was
exposed at mid-thigh level and 4 ligatures (4.0 chromic
gut; Ethicon) were loosely tied around the nerve 2 mm
apart, to produce a loose constriction of the nerve.
Chronic post-ischemic pain was induced by 3 h of hind
paw ischemia followed by reperfusion, as we have done
previously [34,37]. Briefly, rats were anesthetized over a
3 h period with a bolus (55 mg/kg, i.p.) and chronic i.p.
infusion of sodium pentobarbital for 2 h (27.5 mg/kg/h
for two hours). After induction of anesthesia, a Nitrile
70 Durometer O-ring (O-rings West, Seattle, WA) with
7/32 in internal diameter was placed around the rat’s
left ankle joint for 3 h, and then removed to allow
reperfusion.
Western Blotting
Proteins (15 μg total protein per lane) from SCDH sam-
ples homogenized in RIPA buffer were separated by gel
electrophoresis (SDS-PAGE) on a 9% polyacrylamide
gel, and electrotransferred to PVDF membrane. The
membranes were probed with a primary antibody raised
to the C-terminal of atypical PKCs (Santa Cruz SC-216;
1:400) [12], which recognizes PKCζ (72-76 kDa), PKMζ
(50-55 kDa) and PKCl/ι (68-70 kDa). The antibody was
incubated with peroxidase-coupled secondary antibody
(NA 934, GE Life Sciences; 1:30,000), followed by
incubation with chemiluminescent substrate (RPN 2132,
GE Life Sciences). Developed blots were scanned with a
Canon N650U Scanner and analyzed with ImageJ 1.44p
software from NIH.
Intrathecal Drug Administration
Drugs were administered to the intrathecal (i.t.) space
either by lumbar puncture or through chronic indwel-
ling catheters (formalin test only), while rats were
anesthetized with isoflourane (4% induction, 2% mainte-
nance). For lumbar punctures, a 27 gauge needle was
inserted between the L5/L6 vertebrae into the cauda
equina and drugs were administered in a 20 μl volume.
I.t. placement was verified by a flick of the tail on needle
entry and injection. For indwelling catheters, a lumbar
puncture (L5/L6) was performed using a 23 gauge nee-
dle, and PE-32 polyurethane tubing was pushed 3 cm
through the needle to the lumbar enlargement, before
the needle was removed [38]. Injections were given to
conscious rats and i.t. placement was verified by tem-
porary hind paw paralysis following lidocaine injection
(20 μl, 2%) performed immediately after behavioral test-
ing, and the data from rats unaffected by the lidocaine
were not used. ZIP (Myr-SIYRRGARRWRKL-OH,
Tocris), scr-ZIP (Myr-RLYRKRIWRSAGR-OH, Tocris),
NPC-15437 (Sigma) and DHPG were dissolved in 100
mM Tris-saline (pH 7.2).
Behavioral Testing
Naïve rats and rats given i.pl. injections of 20 μl of 0.1%
capsaicin were tested for potential analgesic/anti-hyperal-
gesic/anti-allodynic effects, or for the presence of either
heat and mechanical hyperalgesia/allodynia (at the injec-
tion site for capsaicin-injected rats) by measuring heat or
mechanical nociceptive flexion responses. A nociceptive
flexion response to heat was quantified using the plantar
test [39]. After the rat was habituated to the Plexiglas®
chamber in a Hargreaves apparatus, the plantar surface
of the rat’s affected hind paw was exposed to a noxious
radiant heat source from beneath the floor, and the time
was measured until the rat moved its hind paw. For each
test, three measurements were obtained from each ani-
mal, spaced approximately 10 min apart. The intensity
was set at a level that normally elicited a response within
10-12 sec. A mechanical flexion response was quantified
using von Frey filaments. After the rat was habituated to
a testing box with a wire-mesh floor, a series of von Frey
filaments (0.41-15.1 g) were applied to the ventral surface
of the rat’s hind paw. Filaments were presented using an
up-down procedure, and a 50% response threshold was
calculated for each rat, as previously described [40]. Rats
given i.t. injections of DHPG were tested for mechanical
allodynia in the hind paw using von Frey filaments as
indicated above.
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To assess secondary mechanical allodynia, rats were
tested with von Frey filaments as above, except that
mechanical allodynia was measured at a secondary site at
the heel, approximately 10 mm from the intradermal (i.
d.) injection of 10 μl of 0.5% capsaicin immediately proxi-
mal to the anterior two foot pads, similar to the method
used by Kinnman and Levine [41] (Figure 2c). Secondary
mechanical allodynia was assessed in i.t. drug trials,
together with the assessment of primary allodynia at the
capsaicin (primary) injection site, with or without local
anesthesia (10 μl, 2% lidocaine, i.d.) of the primary site.
Persistent painful responses to a 50 μl i.pl. hind paw
injection of 2.0% formalin were assessed using weighted
means behavioral pain scores as previously described
[27]. Briefly, a pain score was determined for 1 min of
observation during each 3 min block by measuring the
amount of time spent in each of 4 behavioral categories:
0, the injected paw is not favored; 1, the injected paw
has little or no weight on it; 2, the injected paw is ele-
vated and is not in contact with any surface; 3, the
injected paw is licked, bitten or shaken. The time spent
in each category was then multiplied by its category
weight, summated, and divided by the total time the rat
was observed within each time block. The early phase
was defined as responses during the first two 3 min
time blocks, and the late phase as responses between 9
and 45 min post-formalin injection. Drugs were given i.
t. by chronic indwelling catheter as pretreatments 20
min prior to the formalin injection, or as post-treat-
ments 25 min post-formalin injection, i.e., once the late
phase had been established.
For rotarod testing, rats were given 6 daily training
trials for 5 days and 6 post-drug test trials on day 6 on
a rotarod (IITC model 730), with trials spaced 12 min
apart. Each trial lasted a maximum of 120 s, during
which time the rod rotation increased from 0 to 30
rpm. The latency to fall off the rod was recorded, and
latencies for the 6 trials on each day were averaged. On
the sixth day, each rat was given i.t. ZIP (10 nmol/20 μl)
20 min before the start of the trials.
Electrophysiology
For electrophysiology trials, capsaicin (30 μl, 0.1%, i.pl.)
or vehicle was injected in the receptive field of identified
WDR neurons in the SCDH of 27 anesthetized rats, as
previously described [42]. Spontaneous spike frequency
and spikes evoked in WDR neurons in response to
mechanical stimulation with von Frey filaments (1-50 g)
were recorded pre-capsaicin (or vehicle), 30-60 min
post-capsaicin/vehicle and 30-60 min post-drug. Evoked
responses of WDR neurons to noxious heat (a feedback-
controlled halogen heat lamp focused on the hind paw
which heated the skin to 60°C) were also examined pre-
and post-capsaicin. Capsaicin/vehicle was injected inside
the receptive field of each neuron, but distal to the sites
of mechanical or thermal stimulation. ZIP, or scr-ZIP
(50 nmoles in 100 μl), was administered by spinal appli-
cation 90 min after capsaicin/vehicle. Stimulus-evoked
responses were defined as the total number of action
potentials (spikes) evoked during 20 s of stimulation.
Similar electrophysiological methods for mechanical
evoked responses were used in an additional rat that
received spinal application of DHPG (50 nmoles in 100
μl) instead of i.pl. capsaicin.
Statistical analyses
All protein assays and behavioral data were analyzed
using either one-way independent groups or two-way
repeated measures ANOVA followed by orthogonal con-
trasts or multiple comparisons with Fisher’s test. Ortho-
gonal contrasts were used in the formalin test when the
number of potential comparisons was far greater than
the comparisons of interest. Electrophysiological data
converted to percent change from baseline was analyzed
using Friedman’s ANOVA, and raw spike rate data was
analyzed using ANOVA, each followed by multiple com-
parisons with Dunn’s test. Percent change scores were
used because we have previously found that they remain
stable across large variations in baseline neuronal activ-
ity [42]. In all tests, the criterion for statistical signifi-
cance was P < 0.05.
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